Octreotide plus proton pump inhibitor (PPI) versus PPI alone in non-variceal upper gastrointestinal (GI) bleeding in intensive care unit (ICU): A multicenter randomized trial
Publication date: Available online 17 October 2026 Source: The American Journal of the Medical Sciences Author(s): Eman Ibrahim El-Desoki Mahmoud, Islam Ahmed Hassan Ellakany, Sally Wassfi Zaki Hammad, Nermeen Talaat Abd Elfatah
Octreotide plus proton pump inhibitor (PPI) versus PPI alone in non-variceal upper gastrointestinal (GI) bleeding in intensive care unit (ICU): A multicenter randomized trial. // The American Journal of the Medical Sciences. – URL: https://www.sciencedirect.com/science/article/pii/S0002962926003964?dgcid=rss_sd_all
Octreotide plus proton pump inhibitor (PPI) versus PPI alone in non-variceal upper gastrointestinal (GI) bleeding in intensive care unit (ICU): A multicenter randomized trial. The American Journal of the Medical Sciences. https://www.sciencedirect.com/science/article/pii/S0002962926003964?dgcid=rss_sd_all
“Octreotide plus proton pump inhibitor (PPI) versus PPI alone in non-variceal upper gastrointestinal (GI) bleeding in intensive care unit (ICU): A multicenter randomized trial.” The American Journal of the Medical Sciences.
@article{article67941,
title = {Octreotide plus proton pump inhibitor (PPI) versus PPI alone in non-variceal upper gastrointestinal (GI) bleeding in intensive care unit (ICU): A multicenter randomized trial},
journal = {The American Journal of the Medical Sciences},
url = {https://www.sciencedirect.com/science/article/pii/S0002962926003964?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...